Manjie Xing

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.

Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.

Journal: Cancer research

Published: March 02, 2023

Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.

Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.

Journal: Gut

Published: November 03, 2021

Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.

Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.

Journal: Cancer research

Published: June 28, 2021

Author Correction: Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Author Correction: Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Journal: Genome biology

Published: June 18, 2021

Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.

Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.

Journal: Genome medicine

Published: March 18, 2021

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.

Journal: Gut

Published: February 15, 2021

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Journal: Genome biology

Published: January 28, 2021

Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma.

Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma.

Journal: Nature genetics

Published: August 03, 2019

Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.

Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.

Journal: The Journal of clinical investigation

Published: December 10, 2018

HNF4α pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer.

HNF4α pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer.

Journal: Gut

Published: November 29, 2018

Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma.

Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma.

Journal: Gut

Published: September 18, 2018

Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.

Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.

Journal: Nature communications

Published: August 31, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026